Last edition
News about
Neusoft Medical Systems Secures NMPA Approval for China's First Photon-Counting CT
Neusoft Medical Systems has announced that its NeuViz P10 photon-counting CT has received market approval from China's National Medical Products Administration (NMPA).
Osstem Implant Strengthens Global Footprint with India as Key Growth Market
Osstem Implant’s success in India – one of the fastest-growing dental implant markets – is driven by a dual focus on innovation and education.
Genentech Invests USD 700M to Build First East Coast Manufacturing Facility in North Carolina
The project represents an initial investment of more than USD 700 million and is part of Roche’s broader USD 50 billion commitment to strengthen US manufacturing infrastructure and R&D. Once completed, the site will create over 1,900 jobs.
Marking One Year of BioE3 Policy, Dr. Jitendra Singh launched the BioE3 Challenge for Youth and the country’s first National Biofoundry Network, calling it a step towards making biotechnology a driver of India’s economy, environment and employment.
Koanna International and PPI to Form JV to Build New Pharma Manufacturing Facility in Saudi Arabia
Pharma Pharmaceutical Industries & Biological Products (PPI) of Saudi Arabia and Koanna International FZ LLC, a wholly-owned subsidiary of Shilpa Medicare, have signed a definitive agreement to establish a joint venture to set up a pharma manufacturing facility in Saudi Arabia.
US FDA Accepts Gadoquatrane for Review: Bayer
Bayer has submitted New Drug Application (NDA) for low dose contrast agent gadoquatrane to seek approval for contrast-enhanced Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) and other body regions for adults and paediatric patients including neonates.
Unichem Receives EIR with VAI Status from USFDA for Roha API Facility
Unichem Laboratories has announced that it has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Roha active pharmaceutical ingredients (API) facility.
Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26
Since its inception in 2022, Laborate’s direct-to-retail division, Aqualab, has reported consistent year-on-year growth, moving from INR 76 crore in FY 2022–23 to INR 108 crore in FY 2023–24.
Gland Pharma Secures USFDA Approval for Ready-to-Use Vasopressin Injection
The product is bioequivalent and therapeutically equivalent to the reference drug Vasostrict. Vasopressin is indicated for adults with vasodilatory shock who remain hypotensive despite adequate fluid resuscitation and catecholamine support.
Aurobindo Pharma Wins UK MHRA Approval for Dazublys Trastuzumab Biosimilar
CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its trastuzumab biosimilar, Dazublys, used in the treatment of HER2-positive breast and gastric cancers.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy